Ad is loading...
JVMAX
Price
$29.71
Change
-$0.23 (-0.77%)
Updated
Nov 15 closing price
JVMCX
Price
$29.44
Change
-$0.22 (-0.74%)
Updated
Nov 15 closing price
Ad is loading...

JVMAX vs JVMCX

Header iconJVMAX vs JVMCX Comparison
Open Charts JVMAX vs JVMCXBanner chart's image
JHancock Disciplined Value Mid Cap A
Price$29.71
Change-$0.23 (-0.77%)
VolumeN/A
CapitalizationN/A
JHancock Disciplined Value Mid Cap C
Price$29.44
Change-$0.22 (-0.74%)
VolumeN/A
CapitalizationN/A
JVMAX vs JVMCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVMAX vs. JVMCX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMAX is a Buy and JVMCX is a Buy.

FUNDAMENTALS
Fundamentals
JVMAX (23.8B) and JVMCX (23.8B) have equal amount of cash in the bank . JVMAX pays higher dividends than JVMCX: JVMAX (0.67) vs JVMCX (0.01). JVMAX was incepted earlier than JVMCX: JVMAX (27 years) vs JVMCX (13 years). JVMAX (41.00) and JVMCX (41.00) have comparable annual turnover. JVMAX (1000) and JVMCX (1000) have matching initial minimum investment requirements. JVMAX (21.07) and JVMCX (20.18) have marching annual gain over last year. JVMAX return over 5 years is better than : 42.69 vs. JVMCX (39.35).
JVMAXJVMCXJVMAX / JVMCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years13 years-
Gain YTD14.31313.580105%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets23.8B23.8B100%
Annual Yield % from dividends0.670.014,703%
Returns for 1 year21.0720.18104%
Returns for 3 years6.264.67134%
Returns for 5 years42.6939.35108%
Returns for 10 years56.9749.39115%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LEA95.61-0.45
-0.47%
Lear Corp
BKE47.92-0.82
-1.68%
Buckle (The)
ZIMV13.39-0.39
-2.83%
ZimVie
MIST1.70-0.11
-6.08%
Milestone Pharmaceuticals
AKAN1.39-0.09
-6.08%
Akanda Corp